Nestlé Health Science Acquires Majority Stake in Vital Proteins
June 10, 2020
Nestlé Health Science (NHSc), a subsidiary of Nestlé, agreed to acquire a majority stake in Vital Proteins, the US market leader in collagen-based supplements, beverages and food products. Vital Proteins will continue to operate as a standalone business under CEO Kurt Seidensticker, with the deal intended to accelerate global expansion and product innovation.
- Buyers
- Nestlé Health Science (NHSc), Nestlé
- Targets
- Vital Proteins
- Industry
- Food & Beverage
- Location
- Illinois, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Nestlé Acquires The Bountiful Company's Core Vitamin Brands for $5.75B
August 9, 2021
Food & Beverage
Nestlé (via Nestlé Health Science) agreed to acquire the core vitamin and supplement brands of The Bountiful Company from KKR and Carlyle for $5.75 billion, integrating brands such as Nature's Bounty, Solgar, Puritan's Pride and Osteo Bi‑Flex into its NHSc portfolio. The deal (expected/closed in H2 2021) brings roughly 4,000–4,500 employees into Nestlé Health Science and establishes Nestlé as a global leader in vitamins, minerals and nutritional supplements across mass retail, specialty retail and e‑commerce.
-
Nestlé Health Science Acquires Majority Stake in Orgain
February 2, 2022
Food & Beverage
Nestlé Health Science has agreed to acquire a majority stake in Orgain, the U.S. plant-based nutrition company, from founder Dr. Andrew Abraham and Butterfly Equity; both sellers will retain minority ownership positions. Dr. Andrew Abraham will remain CEO of Orgain and the deal will let Nestlé Health Science expand its portfolio of clean, plant-based nutrition products globally; the transaction is subject to customary regulatory approvals.
-
Nestlé Health Science / Société des Produits Nestlé S.A. to acquire Aimmune Therapeutics
August 31, 2020
Pharmaceuticals
Nestlé Health Science (NHSc), via a Nestlé S.A. acquisition subsidiary (Société des Produits Nestlé S.A.), agreed to acquire Aimmune Therapeutics for USD34.50 per share in cash, valuing the company at approximately USD2.6 billion. NHSc already owned ~25.6% of Aimmune; the tender offer is expected to close in Q4 2020 and will expand Nestlé's portfolio with Aimmune's FDA-approved peanut allergy therapy Palforzia.
-
Nestlé Health Science Acquires Nuun from TSG Consumer Partners
May 10, 2021
Food & Beverage
Nestlé Health Science has agreed to acquire Nuun, a Seattle-based hydration supplement brand, from private equity firm TSG Consumer Partners. Financial terms were not disclosed and the transaction was expected to close in the second half of 2021.
-
Wellful Acquires Ancient Nutrition
January 7, 2025
Consumer Products
Wellful, a Kainos Capital portfolio company, has acquired Ancient Nutrition from VMG Partners, Hillhouse Investment and other unit holders. The deal brings Ancient Nutrition's fast-growing VMS portfolio (protein, gut health, greens, and the largest collagen brand in the natural channel) onto Wellful's omnichannel platform to expand distribution into the natural retail channel and strengthen Wellful's supplement offerings; Ancient Nutrition CEO Colt Morton will remain in place.
-
Wellness Natural, Inc. Acquires SimplyProtein
September 29, 2020
Food & Beverage
Wellness Natural, Inc., a newly created Toronto-based natural foods company led by CEO Michael Lines, has acquired the SimplyProtein nutritional snacking brand from Simply Good Foods USA, Inc. The acquisition transfers ownership of SimplyProtein — a plant-based, high-protein snack line sold across Canada and the U.S. — to Wellness Natural, which plans to expand the brand’s distribution and product growth under its leadership and board.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.